Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma
Clinical trial NCT00324727 · COMPLETED
Trial details
- NCT number
- NCT00324727
- Sponsor
- Delcath Systems Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2012-08-01
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.